Market entry
Driving force for advanced medicines
Thanks to our our high excellence and international knowledge in research & development and regulatory affairs we are your perfect partner for an early and global market launch!
about Market ENtry
Making Medicines Accessible Everywhere
With over 15,000 marketing authorizations in more than 80 markets, we help customers bring affordable, value-added, and innovative medicines to patients faster. Our integrated approach — covering regulatory guidance, IP strategy, and supply chain excellence — simplifies your market entry and allows you to focus on brand growth while we manage complexity and compliance.
Facts & figures
Our strong track record in marketing and registration speaks for us
We strongly believe that our high-quality medicines should be available and affordable for all patients – irrespective of their origin or income level. That´s why we always strive for a global and early market entry for our customers. Every year we serve over 500 million patients with our affordable, valued added, and innovative medicines. And we are working every day to better understand patients’ needs and to address the real-world health-challenges by getting closer than ever to patients.
Best-in-class products for patients worldwide
Patient-centered medicines for a global market entry
Tiefenbacher Pharmaceuticals develops, manufactures, and commercializes over 180 medicines — including affordable, value-added, and highly potent drugs — across multiple therapeutic areas and dosage forms. Along the whole pharmaceutical value chain we ensure high-quality, patient-focused solutions that meet diverse healthcare needs while maintaining GMP compliance.
Disease Areas
Oncology
Respiratory
Neuroscience
Cardiovascular, Renal and Metabolism
Immunology, Hepatology and Dermatology
Infectious Diseases
Ophthalmology
Dosage Forms
Tablets
Capsules
Powders
Drops
Inhalers
Transdermal Patches
Eye Drops
Medical Devices
